Synthesis and Characterization of a Family of Molecule-Based Ferrimagnetic Network Solids Containing Fluoro-Substituted Dicyanostilbene Acceptors
作者:Christopher L. Houser、Diego Troya、Gordon T. Yee
DOI:10.1021/acs.cgd.2c01250
日期:2023.5.3
Three new coordination network molecule-based ferrimagnets of the general formula [V(acceptor)2]·x(solvent), where acceptor = 3,3′,5,5′-tetrafluorodicyanostilbene, 3,3′,4,4′,5,5′-hexafluorodicyanostilbene, or 2,2′,3,3′,5,5′,6,6′-octafluorodicyanostilbene and V = vanadium(II), have been prepared with ordering temperatures between 150 and 190 K. Including a previously reported compound, V[DCPFS]2·x(solvent)
ORGANIC ELECTRONIC DEVICE COMPRISING A COMPOUND OF FORMULA (1), DISPLAY DEVICE COMPRISING THE ORGANIC ELECTRONIC DEVICE AS WELL AS COMPOUNDS OF FORMULA (1) FOR USE IN ORGANIC ELECTRONIC DEVICES
申请人:Novaled GmbH
公开号:EP3989301A1
公开(公告)日:2022-04-27
The present invention relates to a compound of formula (i) and an organic electronic device comprising a semiconductor layer which comprises a compound of formula (I).
本发明涉及一种式(i)化合物和一种有机电子器件,该器件包含一个由式(I)化合物组成的半导体层。
ORGANIC COMPOUND OF FORMULA (I) FOR USE IN ORGANIC ELECTRONIC DEVICES, AN ORGANIC ELECTRONIC DEVICE COMPRISING A COMPOUND OF FORMULA (I) AND A DISPLAY DEVICE COMPRISING THE ORGANIC ELECTRONIC DEVICE
申请人:Novaled GmbH
公开号:EP3989304A1
公开(公告)日:2022-04-27
The present invention relates to a compound of formula (i) and an organic electronic device comprising a semiconductor layer which comprises a compound of formula (I).
本发明涉及一种式(i)化合物和一种有机电子器件,该器件包含一个由式(I)化合物组成的半导体层。
Substituted N-arylethyl-2-arylquinoline-4-carboxamides and use thereof
申请人:Bayer Aktiengesellschaft
公开号:US11136296B2
公开(公告)日:2021-10-05
The present application relates to novel substituted N-arylethyl-2-arylquinoline-4-carboxamide derivatives, to processes for preparation thereof, to the use thereof alone or in combinations for treatment and/or prevention of diseases, and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially for treatment and/or prevention of fibrotic and inflammatory disorders.